탈회골 매트릭스 시장 규모, 점유율, 성장 및 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of demineralized bone matrix (DBM) Market

The global demineralized bone matrix (DBM) market was valued at USD 1.25 billion in 2025 and is projected to grow to USD 1.33 billion in 2026, reaching USD 2.21 billion by 2034, registering a CAGR of 6.60% during the forecast period. North America dominated the market with a 44.71% share in 2025, supported by strong healthcare infrastructure and high adoption of advanced orthopedic solutions.

DBM is a type of allograft used in bone repair and spinal fusion procedures. It contains bone morphogenetic proteins (BMPs) that stimulate bone regeneration and healing, making it highly effective in treating fractures, trauma injuries, and orthopedic disorders.

Market Trends

Rising Prevalence of Orthopedic Disorders

The increasing burden of musculoskeletal conditions is a major trend driving the DBM market. Globally, millions suffer from conditions such as osteoporosis, fractures, and osteoarthritis, creating a strong demand for bone grafting materials.

Additionally, the aging population and rising sports-related injuries are contributing to the growing need for orthopedic treatments. As healthcare awareness improves, the adoption of advanced bone graft substitutes like DBM is increasing.

Market Growth Drivers

Increasing Spinal Fusion and Dental Procedures

The rising number of spinal fusion surgeries is a key growth driver for the market. Conditions such as herniated discs and spinal injuries are becoming more common, increasing the demand for DBM products.

Furthermore, the growth in dental implant procedures is boosting market expansion. DBM is widely used in dental surgeries to support bone regeneration and improve implant success rates.

Growing Investments in R&D

Key players are heavily investing in research and development to introduce innovative DBM products and expand their applications. Continuous product innovation is expected to improve treatment outcomes and increase adoption globally.

Market Restraints

High Cost of DBM Products

Despite its benefits, the high cost of DBM products remains a major challenge, especially in emerging economies. The complex manufacturing process, strict regulatory requirements, and need for sterile storage significantly increase costs.

Additionally, limited reimbursement policies for certain procedures, particularly dental bone grafting, restrict widespread adoption.

Market Segmentation

By Product Type

• Putty Segment dominates the market due to its ease of use and effectiveness in orthopedic and dental procedures.
• Gel Segment is expected to grow at a higher CAGR due to its superior biocompatibility and increasing use in trauma and aesthetic surgeries.
• Other forms include fibers and sheets used for specialized applications.

By Application

• Spinal Fusion Segment holds the largest share due to the rising number of spine surgeries and spinal cord injuries.
• Dental Segment is expected to grow significantly due to increasing dental implant procedures.
• Other applications include craniomaxillofacial surgery, joint reconstruction, and long bone procedures.

By End-user

• Hospitals dominate the market due to higher procedure volumes and availability of advanced surgical infrastructure.
• Specialty clinics and other healthcare facilities are also contributing to market growth.

Regional Insights

North America

North America led the market with USD 0.56 billion in 2025 and is projected to reach USD 0.59 billion in 2026. Growth is driven by strong R&D investments and the presence of major industry players.

Europe

Europe accounted for USD 0.32 billion in 2025, growing to USD 0.33 billion in 2026, supported by advanced healthcare systems and rising orthopedic procedures.

Asia Pacific

Asia Pacific is the fastest-growing region, with a market size of USD 0.28 billion in 2025, projected to reach USD 0.30 billion in 2026. Growth is driven by increasing healthcare investments in China, India, and Japan.

Latin America & Middle East & Africa

• Latin America: USD 0.05 billion (2025) -> USD 0.06 billion (2026)
• Middle East & Africa: USD 0.05 billion (2025) -> USD 0.05 billion (2026)

These regions are witnessing steady growth due to improving healthcare infrastructure.

Key Industry Players

Major companies are focusing on product innovation and strategic collaborations. Key players include:

• Medtronic
• Johnson & Johnson
• Zimmer Biomet
• Stryker
• Orthofix

Recent Industry Developments

• 2023: Orthofix and SeaSpine merged to expand biologics portfolio.
• 2022: AlloSource launched AlloFuse DBM graft for orthopedic procedures.
• 2022: Stryker opened a new R&D facility in India.
• 2019: SeaSpine introduced advanced DBM delivery systems.

Conclusion

The global demineralized bone matrix (DBM) market is set to grow steadily from USD 1.25 billion in 2025 to USD 2.21 billion by 2034, driven by increasing orthopedic disorders, rising spinal fusion and dental procedures, and continuous product innovation. While high costs and reimbursement challenges may limit adoption in some regions, ongoing advancements in bone graft technologies and expanding healthcare infrastructure are expected to support long-term market growth. North America will continue to lead, while Asia Pacific is poised to experience the fastest growth, making the DBM market a key segment in the global orthopedic and regenerative medicine industry.

Segmentation By Product Type

• Gel
• Putty
• Others

By Application

• Dental
• Craniomaxillofacial
• Spinal Fusion
• Long Bone Procedures
• Joint Reconstruction
• Other Applications

By End-user

• Hospital
• Specialty Clinics
• Others

By Region

• North America (By Product Type, By Application, By End-user, By Country)
  • U.S. (By Product Type)
  • Canada (By Product Type)
• Europe (By Product Type, By Application, By End-user, By Country/Sub-Region)
  • Germany (By Product Type)
  • U.K. (By Product Type)
  • France (By Product Type)
  • Italy (By Product Type)
  • Spain (By Product Type)
  • Scandinavia (By Product Type)
  • Rest of Europe (By Product Type)
• Asia Pacific (By Product Type, By Application, By End-user, By Country/Sub-Region)
  • China (By Product Type)
  • India (By Product Type)
  • Japan (By Product Type)
  • Australia (By Product Type)
  • Southeast Asia (By Product Type)
  • Rest of Asia Pacific (By Product Type)
• Latin America (By Product Type, By Application, By End-user, By Country/Sub-Region)
  • Brazil (By Product Type)
  • Mexico (By Product Type)
  • Rest of Latin America (By Product Type)
• Middle East & Africa (By Product Type, By Application, By End-user, By Country/Sub-Region)
  • GCC (By Product Type)
  • South Africa (By Product Type)
• Rest of Middle East & Africa (By Product Type)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Prevalence of Orthopaedic Disorders, Key Countries/ Region, 2025
• 4.2. Impact of COVID-19 on Global Demineralized Bone Matrix (DBM) Market
• 4.3. Key Industry Developments
• 4.4. Pipeline Analysis, Key Players

5. Global Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product Type
  • 5.1.1. Gel
  • 5.1.2. Putty
  • 5.1.3. Others
• 5.2. Market Analysis, Insights and Forecast - By Application
  • 5.2.1. Dental
  • 5.2.2. Craniomaxillofacial
  • 5.2.3. Spinal Fusion
  • 5.2.4. Long Bone Procedures
  • 5.2.5. Joint Reconstruction
  • 5.2.6. Other Applications
• 5.3. Market Analysis, Insights and Forecast - By End-user
  • 5.3.1. Hospital
  • 5.3.2. Specialty Clinics
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Geography
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product Type
  • 6.1.1. Gel
  • 6.1.2. Putty
  • 6.1.3. Others
• 6.2. Market Analysis, Insights and Forecast - By Application
  • 6.2.1. Dental
  • 6.2.2. Craniomaxillofacial
  • 6.2.3. Spinal Fusion
  • 6.2.4. Long Bone Procedures
  • 6.2.5. Joint Reconstruction
  • 6.2.6. Other Applications
• 6.3. Market Analysis, Insights and Forecast - By End-user
  • 6.3.1. Hospital
  • 6.3.2. Specialty Clinics
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
    • 6.4.1.1. Product Type
  • 6.4.2. Canada
    • 6.4.2.1. Product Type

7. Europe Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product Type
  • 7.1.1. Gel
  • 7.1.2. Putty
  • 7.1.3. Others
• 7.2. Market Analysis, Insights and Forecast - By Application
  • 7.2.1. Dental
  • 7.2.2. Craniomaxillofacial
  • 7.2.3. Spinal Fusion
  • 7.2.4. Long Bone Procedures
  • 7.2.5. Joint Reconstruction
  • 7.2.6. Other Applications
• 7.3. Market Analysis, Insights and Forecast - By End-user
  • 7.3.1. Hospital
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. U.K.
    • 7.4.1.1. Product Type
  • 7.4.2. Germany
    • 7.4.2.1. Product Type
  • 7.4.3. France
    • 7.4.3.1. Product Type
  • 7.4.4. Spain
    • 7.4.4.1. Product Type
  • 7.4.5. Italy
    • 7.4.5.1. Product Type
  • 7.4.6. Scandinavia
    • 7.4.6.1. Product Type
  • 7.4.7. Rest of Europe
    • 7.4.7.1. Product Type

8. Asia Pacific Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product Type
  • 8.1.1. Gel
  • 8.1.2. Putty
  • 8.1.3. Others
• 8.2. Market Analysis, Insights and Forecast - By Application
  • 8.2.1. Dental
  • 8.2.2. Craniomaxillofacial
  • 8.2.3. Spinal Fusion
  • 8.2.4. Long Bone Procedures
  • 8.2.5. Joint Reconstruction
  • 8.2.6. Other Applications
• 8.3. Market Analysis, Insights and Forecast - By End-user
  • 8.3.1. Hospital
  • 8.3.2. Specialty Clinics
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. Japan
    • 8.4.1.1. Product Type
  • 8.4.2. Australia
    • 8.4.2.1. Product Type
  • 8.4.3. China
    • 8.4.3.1. Product Type
  • 8.4.4. India
    • 8.4.4.1. Product Type
  • 8.4.5. Southeast Asia
    • 8.4.5.1. Product Type
  • 8.4.6. Rest of APAC
    • 8.4.6.1. Product Type

9. Latin America Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product Type
  • 9.1.1. Gel
  • 9.1.2. Putty
  • 9.1.3. Others
• 9.2. Market Analysis, Insights and Forecast - By Application
  • 9.2.1. Dental
  • 9.2.2. Craniomaxillofacial
  • 9.2.3. Spinal Fusion
  • 9.2.4. Long Bone Procedures
  • 9.2.5. Joint Reconstruction
  • 9.2.6. Other Applications
• 9.3. Market Analysis, Insights and Forecast - By End-user
  • 9.3.1. Hospital
  • 9.3.2. Specialty Clinics
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country
  • 9.4.1. Brazil
    • 9.4.1.1. Product Type
  • 9.4.2. Mexico
    • 9.4.2.1. Product Type
  • 9.4.3. Rest of Latin America
    • 9.4.3.1. Product Type

10. Middle East & Africa Demineralized Bone Matrix (DBM) Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product Type
  • 10.1.1. Gel
  • 10.1.2. Putty
  • 10.1.3. Others
• 10.2. Market Analysis, Insights and Forecast - By Application
  • 10.2.1. Dental
  • 10.2.2. Craniomaxillofacial
  • 10.2.3. Spinal Fusion
  • 10.2.4. Long Bone Procedures
  • 10.2.5. Joint Reconstruction
  • 10.2.6. Other Applications
• 10.3. Market Analysis, Insights and Forecast - By End-user
  • 10.3.1. Hospital
  • 10.3.2. Specialty Clinics
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country
  • 10.4.1. GCC Countries
    • 10.4.1.1. Product Type
  • 10.4.2. South Africa
    • 10.4.2.1. Product Type
  • 10.4.3. Rest of Middle East & Africa
    • 10.4.3.1. By Product Type

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles
  • 11.2.1. Medtronic plc
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & Services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Johnson & Johnson (DePuy Synthes)
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & Services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Zimmer Biomet
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & Services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Stryker
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & Services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. Orthofix Holdings, Inc.
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & Services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Xtant Medical
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & Services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. RTI Surgical
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & Services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. HansBioMed
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & Services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Arthrex GmbH
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & Services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Exactech, Inc.
    • 11.2.10.1. Overview
    • 11.2.10.2. Products & Services
    • 11.2.10.3. SWOT Analysis
    • 11.2.10.4. Recent Developments
    • 11.2.10.5. Strategies
    • 11.2.10.6. Financials (Based on Availability)